US Wins Bid To Intervene In Qui Tam Wyeth Drug Suit
The federal government has won a judge's approval to intervene in a whistleblower suit accusing Wyeth Pharmaceuticals Inc. of illegally marketing the kidney transplant drug Rapamune for use in other, unapproved...To view the full article, register now.
Already a subscriber? Click here to view full article